Page last updated: 2024-08-17

galactose and Focal Segmental Glomerulosclerosis

galactose has been researched along with Focal Segmental Glomerulosclerosis in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (22.22)	29.6817
2010's	6 (66.67)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Chang, FC; Chen, YM; Chiang, WC; Chiu, YL; Chou, YH; Fang, YW; Lin, SL; Lin, WC; Shu, KH; Wu, CF; Wu, MS	1
Banks, M; Moudgil, A; Sgambat, K	1
Dwyer, K; Goodman, D; Hill, P; Langham, R; Langsford, D; Robson, K	1
Gassman, J; Gipson, DS; Herreshoff, E; Radeva, M; Reiser, J; Savin, VJ; Sharma, M; Somers, M; Srivastava, T; Stein, DT; Trachtman, H; Vento, S; Wei, C	1
Charba, D; McCarthy, ET; Savin, VJ; Sharma, M; Sharma, R	1
Ammann, H; De Smet, E; Déziel, C; Quérin, S; Rioux, JP	1
Gassman, J; Gipson, D; Greene, T; Joy, M; Pinsk, M; Savin, V; Somers, M; Trachtman, H; Vento, S; Wickman, L	1
Bhaskaran, M; Boctor, FN; Jhaveri, KD; Molmenti, E; Naber, TH; Trachtman, H; Wang, X	1
Kopač, M; Meglič, A; Rus, RR	1

Trials

3 trial(s) available for galactose and Focal Segmental Glomerulosclerosis

Article	Year
Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome. Pediatric nephrology (Berlin, Germany), 2013, Volume: 28, Issue:11 Topics: Adolescent; Child; Child, Preschool; Creatinine; Female; Galactose; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Humans; Kidney Glomerulus; Kidney Transplantation; Male; Nephrotic Syndrome; Permeability; Pilot Projects; Prospective Studies; Proteinuria; Young Adult	2013
Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group. BMC nephrology, 2015, Jul-22, Volume: 16 Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Resistance; Female; Galactose; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Male; Proteinuria; Receptors, Urokinase Plasminogen Activator; Young Adult	2015
Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design. BMC nephrology, 2011, Feb-10, Volume: 12 Topics: Adalimumab; Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atorvastatin; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Galactose; Glomerulosclerosis, Focal Segmental; Heptanoic Acids; Humans; Infant; Lisinopril; Losartan; Middle Aged; Pyrroles; Treatment Outcome; Young Adult	2011

Other Studies

6 other study(ies) available for galactose and Focal Segmental Glomerulosclerosis

Article	Year
Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA Frontiers in immunology, 2021, Volume: 12 Topics: Adult; Case-Control Studies; Complement C5a; Complement Pathway, Alternative; Complement System Proteins; Female; Follow-Up Studies; Galactose; Glomerulonephritis, IGA; Glomerulosclerosis, Focal Segmental; Humans; Immunoglobulin A; Male; Middle Aged	2021
Galactose therapy reduces proteinuria in patients with recurrent focal segmental glomerulosclerosis after kidney transplantation. Nephrology (Carlton, Vic.), 2015, Volume: 20 Suppl 1 Topics: Administration, Oral; Adult; Biopsy; Female; Galactose; Glomerulosclerosis, Focal Segmental; Humans; Kidney Transplantation; Middle Aged; Proteinuria; Recurrence; Remission Induction; Time Factors; Treatment Outcome	2015
Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity. Translational research : the journal of laboratory and clinical medicine, 2008, Volume: 151, Issue:6 Topics: Biological Factors; Chromatography, Affinity; Dialysis; Galactose; Glomerulosclerosis, Focal Segmental; Humans; Kidney Transplantation; Permeability; Plasmapheresis; Proteins; Recurrence	2008
FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:9 Topics: Administration, Oral; Blood Proteins; Creatinine; Galactose; Glomerulosclerosis, Focal Segmental; Humans; Male; Middle Aged; Nephrotic Syndrome; Proteinuria	2009
Treatment of recurrent focal segmental glomerular sclerosis posttransplant with a multimodal approach including high-galactose diet and oral galactose supplementation. Transplantation, 2011, Mar-27, Volume: 91, Issue:6 Topics: Administration, Oral; Combined Modality Therapy; Dietary Supplements; Female; Galactose; Glomerulosclerosis, Focal Segmental; Humans; Middle Aged; Recurrence	2011
Partial remission of resistant nephrotic syndrome after oral galactose therapy. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2011, Volume: 15, Issue:3 Topics: Administration, Oral; Adolescent; Biopsy; Child, Preschool; Drug Resistance; Female; Galactose; Glomerulonephritis, Membranoproliferative; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Male; Nephrotic Syndrome; Proteinuria; Remission Induction	2011